top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Lighting the Way for Improved Detection of Ovarian Cancer
Pafolacianine, an imaging drug that can help surgeons identify ovarian cancer lesions, has recently been accorded FDA approval.
Women's Cancer Research Foundation
Apr 19, 20221 min read
Racial Disparities in Non-Recommendation of Adjuvant Chemotherapy in Ovarian Cancer
In a recent study from Gynecologic Oncology, the authors identified ovarian cancer patients who underwent primary surgery from 2004 to 2015.
Women's Cancer Research Foundation
Mar 16, 20221 min read
Overall Survival and Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
In a recent JAMA study, researchers endeavored to determine if there were differences in overall survival among ovarian cancer patients...
Women's Cancer Research Foundation
Mar 10, 20221 min read
Ovarian Cancer Update
Last year, an estimated 314,000 people worldwide developed ovarian cancer, a condition associated with a 50% mortality rate.
Women's Cancer Research Foundation
Mar 2, 20221 min read
Certain Cancers Increase Stroke Risk, New Analysis Confirms
A 2021 systematic review from Journal of Cancer Survivorship revealed that people living with select cancers have a significantly higher...
Women's Cancer Research Foundation
Feb 11, 20222 min read
Chemo Brain Is Real
“Chemo brain” refers to thinking that is sluggish or fuzzy. Essentially, this condition can interfere with executive functioning...
Women's Cancer Research Foundation
Dec 23, 20212 min read
Clinical Complications of Chemotherapy and Patient-Reported Outcomes After Breast Reconstruction
In a 2021 study, 1881 patients who received either implant-based or autologous breast reconstruction following neoadjuvant or adjuvant...
Women's Cancer Research Foundation
Nov 24, 20211 min read
Do Annual Screenings Reduce Risk of Death in Ovarian Cancer?
Ovarian cancer is an aggressive disease, with a 10-year survival rate of 35%.
Women's Cancer Research Foundation
Nov 5, 20212 min read
Intrauterine Device May Reduce Ovarian Cancer Risk by 30%
Women who have ever used an intrauterine device (IUD) for birth control may have a 30% lower risk for ovarian cancer.
Women's Cancer Research Foundation
Nov 3, 20211 min read
Genital Powder Use and Epithelial Ovarian Cancer
Beginning in 2014, several lawsuits were filed against companies with talc products (baby powder) on behalf of women with ovarian cancer.
Women's Cancer Research Foundation
Oct 30, 20212 min read
No Survival Benefit from Annual Ovarian Cancer Screening in Low-Risk Women
The lifetime risk of developing ovarian cancer in women who are not genetically susceptible to the disease is approximately 2%.
Women's Cancer Research Foundation
Oct 27, 20212 min read
Women’s Health: 50 Years of Progress
Over the past 50 years, there have been tremendous advances in women’s health, particularly in treating cardiovascular disease and cancer.
Women's Cancer Research Foundation
Oct 16, 20212 min read
Improved Ovarian Cancer Patient Survival Rates for Patients With bevacizumab
For the past ten yrs, continued use of bevacizumab therapy in the first-line treatment of ovarian cancer has reportedly improved...
Women's Cancer Research Foundation
Oct 14, 20211 min read
Risk of Late-Onset Breast Cancer in Genetically Predisposed Women
Germline mutations in breast cancer predispose women to develop this malignancy, but in woman 65+years, the risk is not well-defined.
Women's Cancer Research Foundation
Oct 12, 20211 min read
Combination Strategies Reshape Treatment Paradigm for Advanced Endometrial Cancer
Initially, pembrolizumab was approved as a monotherapy for patients with microsatellite instability-high recurrent endometrial cancer.
Women's Cancer Research Foundation
Oct 8, 20211 min read
Blood Test for Many Cancer Types as Supplement to Screening
The blood test uses next-generation sequencing to analyze the arrangement of circulating cell-free DNA from a blood sample.
Women's Cancer Research Foundation
Oct 5, 20211 min read
Women With Ovarian Cancer at Higher Risk for Mental Health Disorders
Ovarian cancer survivors who had a mental health diagnosis demonstrated an 80% higher risk for mortality.
Women's Cancer Research Foundation
Aug 31, 20212 min read
Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers
Oral contraceptive use potentially reduces the risk of breast, ovarian, and endometrial cancers.
Women's Cancer Research Foundation
Aug 12, 20211 min read
Drug Boosts Survival for Women with Advanced Ovarian Cancer
Lynparza (Olaparib), a targeted cancer therapy, has recently shown a meaningful survival benefit after 5 years.
Women's Cancer Research Foundation
Aug 5, 20211 min read
Appropriateness of Specific Chemotherapy Regimens in Elderly Patients Diagnosed with Ovarian Cancer
Efficacy and safety of first-line single-agent carboplatin vs carboplatin plus paclitaxel for vulnerable older adult women with ovarian....
Women's Cancer Research Foundation
Jul 5, 20211 min read
bottom of page